https://euroapteek.eeE-apteek | Euroapteek.eeEuroapteek e-apteegist saate osta kosmeetikatooteid, toidulisandeid ja käsimüügiravimeid. Lisaks saate e-apteegist oste sooritada igal pool, Teile sobival ajal.
Name
OÜ Pharmandia
Registry code
14213834
VAT number
EE101956697
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
01.03.2017 (7)
Financial year
01.01-31.12
Capital
3 000.00 €
Activity
47731 - Dispensing chemist in specialised stores
3 052 501 €
-70 001 €
-2%
2 045 €
(estimate is approximate)
-1 293 700 €
4
Submitted
No tax arrears
5%
-12%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Omanikukonto: Hanna Plato 16.05.1981 (43) | 100% - 3 000.00 EUR | Board member | Direct ownership |
| 2019 18.01.2021 | 2020 30.06.2021 | 2021 17.06.2022 | 2022 14.06.2023 | 2023 14.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 2 386 847 € | 2 574 755 € | 2 589 684 € | 2 778 271 € | 3 052 501 € |
| Net profit (loss) for the period | -315 198 € | -133 923 € | 11 184 € | -100 002 € | -70 001 € |
| Profit Margin | -13% | -5% | 0% | -4% | -2% |
| Current Assets | 550 868 € | 726 816 € | 720 920 € | 784 347 € | 584 476 € |
| Fixed Assets | 662 291 € | 745 194 € | 652 163 € | 559 697 € | 10 925 € |
| Total Assets | 1 213 159 € | 1 472 010 € | 1 373 083 € | 1 344 044 € | 595 401 € |
| Current Liabilities | 1 746 512 € | 2 095 101 € | 1 984 991 € | 2 055 954 € | 1 889 101 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | -533 353 € | -623 091 € | -611 908 € | -711 910 € | -1 293 700 € |
| Employees | 20 | 18 | 2 | 3 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 753 518.42 € | 9 852.65 € | 14 025.78 € | 8 |
| 2023 Q4 | 972 880.67 € | 15 614.89 € | 15 799.45 € | 7 |
| 2023 Q3 | 666 393.37 € | 8 055.92 € | 10 197.94 € | 10 |
| 2023 Q2 | 696 481.43 € | 8 940.27 € | 11 907.67 € | 8 |
| 2023 Q1 | 702 005.59 € | 8 860.66 € | 13 760.17 € | 7 |
| 2022 Q4 | 747 508.34 € | 6 478.23 € | 13 114.5 € | 7 |
| 2022 Q3 | 637 973.8 € | 12 613.9 € | 13 484 € | 7 |
| 2022 Q2 | 674 949.68 € | 4 374.73 € | 6 432.19 € | 4 |
| 2022 Q1 | 682 944.43 € | - | 6 433.75 € | 2 |
| 2021 Q4 | 727 139.29 € | 12 311.97 € | 4 578.03 € | 2 |
| 2021 Q3 | 626 040.68 € | 1 422.44 € | 6 566.25 € | 2 |
| 2021 Q2 | 633 747.59 € | 7 673.45 € | 6 371.59 € | 2 |
| 2021 Q1 | 595 806.16 € | 6 037.37 € | 6 551.77 € | 2 |
| 2020 Q4 | 657 113.71 € | 25 561.71 € | 27 497.35 € | 2 |
| 2020 Q3 | 572 924.23 € | 43 309.08 € | 45 895.74 € | 21 |
| 2020 Q2 | 698 242.78 € | 48 417.34 € | 48 053.11 € | 22 |
| 2020 Q1 | 681 974.49 € | 49 919.72 € | 46 884.77 € | 24 |
